Cornelia Reininger

Compartment-model based quantification of beta-amyloid binding with Florbetaben PET inAlzheimer'sdisease and control subjects

Masanori Ichise, Marianne Patt, Georg A. Becker, 2010, NeuroImage.

Kinetic modeling of florbetaben binding to beta-amyloid in human brains using one and two input functions

Masanori Ichise, Marianne Patt, Henryk Barthel, 2010, NeuroImage.

Renal artery stenosis: functional assessment with dynamic MR perfusion measurements--feasibility study.

Maximilian F Reiser, Stefan O Schoenberg, Cornelia Reininger, 2006, Radiology.

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies

Jacques Darcourt, Cornelia Reininger, Jan Booij, 2009, British Journal of Psychiatry.

DETECTION OF PRODROMAL ALZHEIMER'S DISEASE WITH 18F-FLORBETABEN Aβ IMAGING: A PROSPECTIVE OUTCOME STUDY

John Seibyl, Victor L. Villemagne, Beate Rohde, 2014, Alzheimer's & Dementia.

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

John Seibyl, Yasuomi Ouchi, Ana M. Catafau, 2015, Alzheimer's & Dementia.

Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer’s disease and healthy volunteers

Swen Hesse, Marianne Patt, Osama Sabri, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

PET Quantification of 18F-Florbetaben Binding to β-Amyloid Deposits in Human Brains

Masanori Ichise, Marianne Patt, Osama Sabri, 2013, The Journal of Nuclear Medicine.

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

John Seibyl, Katharina Buerger, Osama Sabri, 2011, The Lancet Neurology.